Contact us

News

Image articles blog (3)
Rheumatoid Arthritis: Why Target the Appropriate Biotherapy?
Biotherapies: A Revolution in Rheumatoid Arthritis Treatment Biotherapies represent a new generation...
Image articles blog (3)
Artificial Intelligence in the Service of Remission in Rheumatoid Arthritis
mYXpression is based on a simple principle: each patient is unique and responds differently to prescribed...
Image articles blog (1)
mYXpression participate to BIO2024 in San Diego, the largest event for biotechnology.
mYXpression is pleased to announce its participation at the Bio International Convention 2024, which...
Image articles blog (2)
mYXpression begins a clinical trial to demonstrate the efficacy of RITI® rhumato
mYXpression begins a clinical trial to demonstrate the efficacy of RITI® rhumato, a test to help prescribe...
Image articles blog (3)
mYXpression receives CE mark clearance for its software Pear 2.0, a key milestone to launch RITI®, a test to assist rheumatologists in their prescription of biologics.
This regulatory approval is the achievement of a 2-year work by all mYXpression employees and partners....
Search
Categories
+33 (0) 380 675 486
Contact us
Contact us
mYXpression 2024, All Rights Reserved - Design by BWA